Annual Meeting of the American Association for Cancer Research (AACR), April 14-19, 2023, Orlando, Florida (US)
Our Director R&D, Iman Schultz, PhD, will attend the 2023 Annual Meeting of the American Association for Cancer Research held in Orlando, Florida (US), April 14-19, and present data on the discovery of the novel promising immunotherapy target ‘ZP3-Cancer’. ZP3-Cancer is highly selectively enriched in cancer, particularly in lung, colorectal, ovarian and prostate cancer.
The AACR Annual Meeting covers the latest breakthroughs in cancer, from early discoveries to late stage clinical trials, and attracts top speakers in the field from all over the world.
Looking forward to presenting our data in Orlando.